Preliminary Study on the Development and Reliability and Validity of Attention Rating Scale

NCT06207279 | Recruiting

• 1 other identifier: 2022-056
• Study Type: observational
• Target: 240
• Locations: 1 country
• Sites: 1

Brief Summary

This study, based on preliminary experimental results, literature review, and expert consultations, developed the Attentional Rating Scale (ARS). The aim was to rapidly assess participants' attention and potential influencing factors. The research focused on the scale's reliability and validity among healthy adults. Additionally, the Attention Network Test (ANT) served as the gold standard for evaluating attention. The study attempted to identify correlations between various dimensions of attention and the three attentional networks.

Conditions

Depression; Insomnia; Attention Disturbances; Healthy

Outcome Measures

Primary Outcomes (2)

• Developing Attention Rating Scale（ARS）

  The Attention Assessment Scale is developing as a tool to assess attention ability designed for self-rating scale. Its purpose is to swiftly evaluate the attention levels of adults. There are 30 items in ARS. The minimum value is 1 and maximum value is 5, and the higher scores mean a better outcome for attention ability.

  3 months

• Reliability and Validity of the Attention Assessment Scale.

  Reliability 1. Cronbach α of ARS should be above 0.8 that means good reliability. 2. The intra group correlation value for retesting reliability should be above 0.8 that means good retesting reliability. Validity 1. The split half reliability measured and factor analysis to test constuctive validity of ARS. 2. The correlation coefficient r with ANT and the correlation coefficient r with THAT should be statistic significant, that means good validity of attention ability for Attention Assessment Scale.

  2 years

Study Arms (4)

Major Depressive Disorder

Patients meeting the diagnostic criteria for Major Depressive Disorder (MDD) according to DSM-5.

Diagnostic Test: rating

Chronic Insomnia Disorder

Patients meeting the diagnostic criteria for Chronic Insomnia Disorder according to ICSD-3.

Diagnostic Test: rating

Health Control

Healthy population.

Diagnostic Test: rating

Attention Deficit and hyperactivity Disorder

Patients meeting the diagnostic criteria for Attention Deficit and hyperactivity Disorder (ADHD) according to DSM-5.

Diagnostic Test: rating

Interventions

rating DIAGNOSTIC_TEST

rating scales, test ANT

Attention Deficit and hyperactivity Disorder; Chronic Insomnia Disorder; Health Control; Major Depressive Disorder

Eligibility Criteria

• Age: 18 Years - 60 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

Sixty cases of patients diagnosed with Major Depressive Disorder (MDD), ADHD and insomnia disorder separately are recruited from outpatient clinics and hospital wards. Additionally, sixty healthy individuals are recruited from the community as control subjects.

You may qualify if:

• Major Depressive Disorder (MDD) or attention deficit hyperactivity disorder (ADHD) diagnosed according to DSM-5, or Chronic Insomnia Disorder diagnosed according to ICSD-3
• Ages between 18 and 60 years old
• Right-handed
• Educational level ≥5 years or IQ ≥90, capable of understanding and reading Chinese.

You may not qualify if:

• Currently diagnosed with any other DSM-5 mental disorders (according to MINI 7.0) or ICSD-3 sleep-wake disorders, apart from MDD, ADHD or insomnia disorder
• Currently and past history of neurological disorders and physical illnesses with subjectives
• Consumed alcohol in the week preceding the enrollment
• Using antidepressants, antipsychotics, mood stabilizers, or other central nervous system-acting drugs for at least 4 weeks in the current episode
• Undergoing any physical treatments such as ECT, neuromodulation therapy or Traditional Chinese Medicine treatment in the past 6 months
• Refused to sign the informed consent form

Sponsors & Collaborators

• Peking University Sixth Hospital: lead

Study Sites (1)

Peking University Sixth Hospital

Beijing, Beijing Municipality, 100191, China

RECRUITING

MeSH Terms

Conditions

Depression; Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Behavioral Symptoms; Behavior; Sleep Disorders, Intrinsic; Dyssomnias; Sleep Wake Disorders; Nervous System Diseases; Mental Disorders

Study Officials

• Xueqin Wang, doctor

  Peking University Sixth Hospital

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Xinyang Zhang, master

CONTACT

+8610-62723770; zhangxinyang2022@bjmu.edu.cn

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principle Investigator

Study Record Dates

• First Submitted: October 10, 2023
• First Posted: January 16, 2024
• Study Start: September 28, 2023
• Primary Completion: December 31, 2024
• Study Completion: December 31, 2024
• Last Updated: February 28, 2024

Record last verified: 2024-02

Data Sharing

• IPD Sharing: Will not share

Locations

CN (1)